Publications by authors named "Georges Bertrand"

Claim this Profile
S
Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial.
Sarah K Browne, John J Suschak, Shaheen Tomah, Julio A Gutierrez, Jay Yang, Bertrand Georges

JHEP Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model.
Alexandria Dickson, Elizabeth Geerling, E Taylor Stone, Mariah Hassert, Tara L Steffen, Bertrand Georges

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts.
Michael D Schultz, John J Suschak, Davide Botta, Aaron Silva-Sanchez, R Glenn King, Bertrand Georges

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge.
R Glenn King, Aaron Silva-Sanchez, Jessica N Peel, Davide Botta, Alexandria M Dickson, Bertrand Georges

Vaccines (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial.
Sybil Tasker, Anna Wight O'Rourke, Anvar Suyundikov, Peta-Gay Jackson Booth, Stephan Bart, Bertrand Georges

Vaccines (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 in mice.
Rodney G King, Aaron Silva-Sanchez, Jessica N Peel, Davide Botta, Selene Meza-Perez, Bertrand Georges

bioRxiv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre.
Victoria M W Gould, James N Francis, Katie J Anderson, Bertrand Georges, Alethea V Cope

Front Microbiol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing cellular immunogenicity to peptide-based vaccine candidates using a fluorocarbon antigen delivery system.
James N Francis, Jean-François Thaburet, Dominique Bonnet, Philip J Sizer, Carlton B Brown, Bertrand Georges

Vaccine· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans.
Jeannette M Watson, James N Francis, Sofie Mesens, Gabriel A Faiman, Jill Makin, Bertrand Georges

Virol J· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel peptide-based pan-influenza A vaccine: a double blind, randomised clinical trial of immunogenicity and safety.
James N Francis, Campbell J Bunce, Claire Horlock, Jeannette M Watson, Steven J Warrington, Bertrand Georges

Vaccine· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of arsenic and antimony distribution within plants growing at an old mine site in Ouche (Cantal, France) and identification of species suitable for site revegetation.
Ulrike Jana, Vincent Chassany, Georges Bertrand, Maryse Castrec-Rouelle, Emmanuel Aubry

J Environ Manage· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of a HLA II promiscuous peptide cocktail as potential vaccine against EBV latency II malignancies.
Stéphane Depil, Olivier Moralès, Florence A Castelli, Nadira Delhem, Violaine François, Bertrand Georges

J Immunother· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
Florence A Castelli, Mélanie Leleu, Sandra Pouvelle-Moratille, Sandrine Farci, Hassane M Zarour, Bertrand Georges

Eur J Immunol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide-binding assays and HLA II transgenic Abeta degrees mice are consistent and complementary tools for identifying HLA II-restricted peptides.
Stéphane Depil, Gerhild Angyalosi, Olivier Moralès, Myriam Delacre, Nadira Delhem, Bertrand Georges

Vaccine· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
Lbachir BenMohamed, Georges Bertrand, Cory D McNamara, Helene Gras-Masse, Juergen Hammer

J Virol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.
Florence A Castelli, Cécile Buhot, Alain Sanson, Hassane Zarour, Sandra Pouvelle-Moratille, Bertrand Georges

J Immunol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidences of conformational changes in class II Major Histocompatibility Complex molecules that affect the immunogenicity.
Raphaële Neveu, Claude Auriault, Gerhild Angyalosi, Bertrand Georges

Mol Immunol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis